TW371662B - Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives - Google Patents

Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives

Info

Publication number
TW371662B
TW371662B TW082100500A TW82100500A TW371662B TW 371662 B TW371662 B TW 371662B TW 082100500 A TW082100500 A TW 082100500A TW 82100500 A TW82100500 A TW 82100500A TW 371662 B TW371662 B TW 371662B
Authority
TW
Taiwan
Prior art keywords
pyrimidine derivatives
substituted alkenyl
purine
phosphonomethoxyalkyl
antiviral
Prior art date
Application number
TW082100500A
Other languages
English (en)
Inventor
John C Martin
Joanne J Bronson
Kuo-Long Yu
Original Assignee
Acad Of Science Czech Republic
Rega Stichting
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acad Of Science Czech Republic, Rega Stichting filed Critical Acad Of Science Czech Republic
Application granted granted Critical
Publication of TW371662B publication Critical patent/TW371662B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
TW082100500A 1991-10-11 1993-01-27 Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives TW371662B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77783591A 1991-10-11 1991-10-11

Publications (1)

Publication Number Publication Date
TW371662B true TW371662B (en) 1999-10-11

Family

ID=25111455

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082100500A TW371662B (en) 1991-10-11 1993-01-27 Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives

Country Status (14)

Country Link
US (1) US5696263A (zh)
EP (1) EP0630381B1 (zh)
JP (1) JP3497505B2 (zh)
KR (1) KR0184530B1 (zh)
AT (1) ATE151432T1 (zh)
AU (1) AU661347B2 (zh)
CA (1) CA2120743C (zh)
CZ (1) CZ287745B6 (zh)
DE (1) DE69218968T2 (zh)
HU (1) HU225970B1 (zh)
IL (1) IL103410A (zh)
NO (1) NO305518B1 (zh)
TW (1) TW371662B (zh)
WO (1) WO1993007157A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817647A (en) * 1993-04-01 1998-10-06 Merrell Pharmaceuticals Inc. Unsaturated acetylene phosphonate derivatives of purines
EP0618214A1 (en) * 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Unsaturated phosphonate derivatives of purines and pyrimidines
US5798340A (en) 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
IT1270008B (it) * 1994-09-23 1997-04-16 Ist Superiore Sanita Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US8586781B2 (en) 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
CN100402539C (zh) 2000-07-21 2008-07-16 吉里德科学公司 核苷酸膦酸酯类似物前药及其筛选和制备方法
NZ530685A (en) 2001-06-29 2006-09-29 Acad Of Science Czech Republic 6-'2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
KR101102815B1 (ko) 2003-06-16 2012-01-05 케이.유.루벤 리서치 앤드 디벨럽먼트 항바이러스 뉴클레오티드 유사체인 포스포네이트기를 갖는 피리미딘 화합물
KR101033290B1 (ko) 2004-07-02 2011-05-09 주식회사 엘지생명과학 다이아이소프로필((1-(하이드록시메틸)-사이클로프로필)옥시)메틸포스포네이트의 새로운 제조 방법
FR2908133B1 (fr) 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CN102781462A (zh) * 2009-08-27 2012-11-14 伊皮芬尼生物科学公司 新的核苷膦酸酯及类似物
US9334300B2 (en) * 2011-08-01 2016-05-10 Mbc Pharma, Inc. Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
ES2874774T3 (es) 2011-12-22 2021-11-05 Geron Corp Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros
BR122022008466B1 (pt) 2017-12-07 2023-12-05 Emory University Uso de um composto

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556643A (en) * 1982-07-26 1985-12-03 Agracetus Assay method and probe for polynucleotide sequences
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CA1254525A (en) * 1983-04-13 1989-05-23 Christine L. Brakel Kit for terminally chemically labeling dna
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
EP0146039A3 (en) * 1983-12-12 1986-08-27 Miles Inc. Hybridization assay with immobilization of hybrids by antihybrid binding
EP0144913A3 (en) * 1983-12-12 1986-08-20 Miles Inc. Hybridization assay employing labeled probe and anti-hybrid
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU613592B2 (en) * 1986-11-18 1991-08-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives

Also Published As

Publication number Publication date
NO941275D0 (no) 1994-04-08
ATE151432T1 (de) 1997-04-15
EP0630381B1 (en) 1997-04-09
CZ287745B6 (cs) 2001-01-17
EP0630381A4 (en) 1995-01-04
EP0630381A1 (en) 1994-12-28
WO1993007157A1 (en) 1993-04-15
NO305518B1 (no) 1999-06-14
HUT66770A (en) 1994-12-28
CZ84594A3 (en) 1995-07-12
NO941275L (no) 1994-06-10
US5696263A (en) 1997-12-09
AU661347B2 (en) 1995-07-20
CA2120743C (en) 2005-03-08
HU9401002D0 (en) 1994-07-28
IL103410A (en) 1998-01-04
DE69218968T2 (de) 1997-10-09
KR0184530B1 (ko) 1999-05-15
AU2783192A (en) 1993-05-03
HU225970B1 (en) 2008-01-28
JPH07503453A (ja) 1995-04-13
IL103410A0 (en) 1993-03-15
JP3497505B2 (ja) 2004-02-16
DE69218968D1 (en) 1997-05-15
CA2120743A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
TW371662B (en) Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives
MY107843A (en) Anti-viral compounds.
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
EP1808434A3 (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine fo the treatment of hepatitis B
ES2054693T3 (es) Compuestos antivirales.
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
TW366339B (en) Derivatives of benzimidazolyl-cyclopentanediol, -cyclopentanol and -cyclopentenol, and pharmaceutical composition containing the same
EA200100494A1 (ru) Синтез 1,3-оксаселеноланнуклеозидов, обладающих активностью против вируса иммунодефицита человека и против вируса гипатита-b
AU2476388A (en) Therapeutic necleosides
FI970786A (fi) 4-/2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena
AU3170193A (en) Therapeutic nucleosides
CA2040854A1 (en) Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
MY104976A (en) Antiviral compounds
MY113560A (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
TH10132A (th) การยับยั้งไวรัสที่ทำให้เกิดภูมิคุ้มกันบกพร่องในคน (hiv) โดยการทำงานร่วมกันแบบเสริมของอนุพันธุ์นิวคลีโอไซด์

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent